ATE519491T1 - Zubereitung von aphanizomenon flos aquae, extrakte und gereinigte komponenten zur behandlung von neurologischen, neurodegenerativen und stimmungsstörungen - Google Patents

Zubereitung von aphanizomenon flos aquae, extrakte und gereinigte komponenten zur behandlung von neurologischen, neurodegenerativen und stimmungsstörungen

Info

Publication number
ATE519491T1
ATE519491T1 AT07764849T AT07764849T ATE519491T1 AT E519491 T1 ATE519491 T1 AT E519491T1 AT 07764849 T AT07764849 T AT 07764849T AT 07764849 T AT07764849 T AT 07764849T AT E519491 T1 ATE519491 T1 AT E519491T1
Authority
AT
Austria
Prior art keywords
neurodegenerative
neurological
treatment
extracts
preparation
Prior art date
Application number
AT07764849T
Other languages
English (en)
Inventor
Stefano Scoglio
Franco Canestrari
Serena Benedetti
Yanina Benedetti
Maria Delgado-Esteban
Original Assignee
Nutratec S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutratec S R L filed Critical Nutratec S R L
Application granted granted Critical
Publication of ATE519491T1 publication Critical patent/ATE519491T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07764849T 2006-06-27 2007-06-26 Zubereitung von aphanizomenon flos aquae, extrakte und gereinigte komponenten zur behandlung von neurologischen, neurodegenerativen und stimmungsstörungen ATE519491T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81659306P 2006-06-27 2006-06-27
PCT/EP2007/005622 WO2008000430A2 (en) 2006-06-27 2007-06-26 Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders

Publications (1)

Publication Number Publication Date
ATE519491T1 true ATE519491T1 (de) 2011-08-15

Family

ID=38529410

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07764849T ATE519491T1 (de) 2006-06-27 2007-06-26 Zubereitung von aphanizomenon flos aquae, extrakte und gereinigte komponenten zur behandlung von neurologischen, neurodegenerativen und stimmungsstörungen

Country Status (20)

Country Link
US (1) US9522167B2 (de)
EP (1) EP2046354B1 (de)
JP (1) JP5259585B2 (de)
KR (1) KR20090035490A (de)
CN (1) CN101478980B (de)
AT (1) ATE519491T1 (de)
AU (1) AU2007264042B2 (de)
CA (1) CA2656154C (de)
DK (1) DK2046354T3 (de)
ES (1) ES2370533T3 (de)
HR (1) HRP20110771T1 (de)
IL (1) IL196132A (de)
MY (1) MY146594A (de)
PL (1) PL2046354T3 (de)
PT (1) PT2046354E (de)
RS (1) RS52072B (de)
RU (1) RU2441663C2 (de)
SI (1) SI2046354T1 (de)
WO (1) WO2008000430A2 (de)
ZA (1) ZA200900747B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20070391A1 (it) * 2007-06-05 2008-12-06 Medestea Res & Production S P Composizione di integratore alimentare,farmaco o dispositivo medicale e suo impiego per sopprimere l'appetito, migliorare tono ed umore, con attivita antidepressiva naturale e con effetto antiastenico
KR100969325B1 (ko) * 2010-02-08 2010-07-09 인천대학교 산학협력단 홍조류로부터 비독성 자외선 차단용 추출물을 제조하는 방법 및 이를 이용한 비독성 자외선 차단제
US20140199380A1 (en) * 2010-05-11 2014-07-17 Benzion Geshuri Pharmaceutical composition comprising an algae adapted to increase the efficacy of an enzymatic inhibitor
US8906361B2 (en) * 2011-03-28 2014-12-09 John V. Cappello Anti-aging formulations
CU23963B1 (es) * 2011-07-01 2013-12-11 Ct De Ingeniería Genética Y Biotecnología Composiciones farmacéuticas a partir de derivados de la c-ficocianina y combinaciones con interferones del tipo i para el tratamiento de enfermedades cerebrales isquémicas y neurodegenerativas
EP3362077A1 (de) * 2015-09-03 2018-08-22 SCOGLIO, Stefano Cyanobakterielle mikroalgen, phycocyanin und phycocyanobilin zur günstigen hemmung der aktivität des udp-gdh enzyms bei signifikanter erhöhung der absorption und zirkulation von curcumin
JP7257479B2 (ja) * 2016-04-27 2023-04-13 長瀬産業株式会社 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法
JP6719267B2 (ja) * 2016-04-27 2020-07-08 長瀬産業株式会社 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法
JP6964707B2 (ja) * 2016-04-27 2021-11-10 長瀬産業株式会社 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法
AU2017259736A1 (en) * 2016-05-02 2018-12-20 Stefano Scoglio The use of phycocyanins, purified or as present in cyanobacterial microalgae or extracts thereof, as prebiotics, to enhance the viability, gastrointestinal survival, pathogen-fighting ability, and the overall health-enhancing properties of probiotic cultures and products.
AU2018328692A1 (en) 2017-09-06 2019-08-22 Stefano Scoglio The transdermal use of cyanobacterial algae, and/or extracts thereof, via low or high intensity transporation devices for beauty and health enhancing purposes
KR102003911B1 (ko) * 2018-02-23 2019-07-25 씨제이제일제당 주식회사 마이코스포린 유사 아미노산을 생산하는 미생물 및 이를 이용한 마이코스포린 유사 아미노산의 생산방법
CN108484438A (zh) * 2018-03-06 2018-09-04 佛山科学技术学院 一种从紫菜中提取类菌胞素氨基酸的方法
CN108421031A (zh) * 2018-04-13 2018-08-21 桂林医学院 藻蓝蛋白在制备防治帕金森病药物中的应用
CN108752445B (zh) * 2018-06-20 2021-04-30 广东药科大学 一种螺旋藻蛋白的制备工艺及其神经保护用途
FR3103106B1 (fr) * 2019-11-19 2022-05-27 Algosource Extrait liquide aqueux de Spiruline pour la prévention et/ou le traitement des neuropathies périphériques chimio-induites et leurs symptômes, composition et utilisation correspondantes.
CN111700903B (zh) * 2020-08-07 2022-03-11 华侨大学 一种紫菜多糖的应用及紫菜多糖的制备方法
KR102694496B1 (ko) * 2021-08-18 2024-08-13 전남대학교산학협력단 마이코스포린-유사 아미노산을 유효성분으로 포함하는 비만 예방 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5865216A (ja) * 1981-09-16 1983-04-18 Dainippon Ink & Chem Inc 抗腫瘍剤
US5455276A (en) * 1993-05-20 1995-10-03 Sabelli; Hector C. Method for treating depression
US6814961B1 (en) * 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
ES2546332T3 (es) * 2005-06-24 2015-09-22 Desert Lake Technologies Extractos purificados de algas verde azuladas y método de uso

Also Published As

Publication number Publication date
SI2046354T1 (sl) 2011-11-30
RU2441663C2 (ru) 2012-02-10
EP2046354A2 (de) 2009-04-15
ES2370533T3 (es) 2011-12-19
AU2007264042A1 (en) 2008-01-03
JP5259585B2 (ja) 2013-08-07
US20090311286A1 (en) 2009-12-17
RU2008151175A (ru) 2010-06-27
MY146594A (en) 2012-08-30
IL196132A0 (en) 2009-09-22
HRP20110771T1 (hr) 2011-11-30
EP2046354B1 (de) 2011-08-10
PT2046354E (pt) 2011-11-09
JP2009541388A (ja) 2009-11-26
CA2656154A1 (en) 2008-01-03
IL196132A (en) 2014-06-30
CN101478980B (zh) 2013-03-20
US9522167B2 (en) 2016-12-20
ZA200900747B (en) 2010-05-26
PL2046354T3 (pl) 2012-01-31
WO2008000430A2 (en) 2008-01-03
CN101478980A (zh) 2009-07-08
KR20090035490A (ko) 2009-04-09
WO2008000430A3 (en) 2008-03-27
DK2046354T3 (da) 2011-10-31
AU2007264042B2 (en) 2012-01-12
CA2656154C (en) 2017-02-28
RS52072B (sr) 2012-06-30

Similar Documents

Publication Publication Date Title
DK2046354T3 (da) Aphanizomenon Flos Aquae-fremstilling, ekstrakter og oprensede bestanddele deraf til behandling af neurologiske, neurodegenerative og humørforstyrrelser
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
ATE542801T1 (de) Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
EP2118300A4 (de) Verhinderung und behandlung synukleinopathischer und amyloidogener krankheiten
TNSN08400A1 (en) Organic compounds and their uses
NO20034056D0 (no) Proliferative sykdommer
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2007121188A3 (en) Compositions and methods of using r(+) pramipexole
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
TW200730515A (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
MX2010003392A (es) Composiciones de limpieza y/o tratamiento.
MX2007009356A (es) Compuestos y composiciones como moduladores de ppar.
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
EA201101579A1 (ru) Имидазо[1,2-а]пиридин-2-ил-фенил производные для лечения рака
TW200616656A (en) Angelicae sinensis extracts useful for treatment of cancers
DE50109156D1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
MY149492A (en) Immunoglobulins directed against nogo
PH12017501312A1 (en) Method for producing hop extract
EP4426322A4 (de) Mesenchymale stammzellen zur prävention und gezielten behandlung von krebs und anderen erkrankungen
WO2007012057A3 (en) Vegetation water composition for treatment of inflammatory skin conditions
NO20076663L (no) Immunoglobuliner
ATE407574T2 (de) Fraktionen und zubereitungen aus milch zur behandlung und / oder vorbeugung cox-2 vermittelter krankheiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2046354

Country of ref document: EP